{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:15:00Z","timestamp":1793060100322,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007192","name":"Rijksinstituut voor Volksgezondheid en Milieu","doi-asserted-by":"publisher","award":["S\/115006"],"award-info":[{"award-number":["S\/115006"]}],"id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cmi.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:24:17Z","timestamp":1766215457000},"page":"610-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CefiderocolFinder: a tool for detecting genetic adaptations implicated in cefiderocol resistance"],"prefix":"10.1016","volume":"32","author":[{"given":"Bryan","family":"van den Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan W.","family":"Notermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelianne J.","family":"Verkaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.A.","family":"Rossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni P.A.","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.12.009_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2025.12.009_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad276","article-title":"An NDM-Producing Escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward pan-\u03b2-lactam resistance","volume":"10","author":"Simner","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib4","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacteria","volume":"62","author":"Ito","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10096-023-04671-0","article-title":"Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal","volume":"42","author":"Daoud","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jgar.2021.12.017","article-title":"Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan","volume":"28","author":"Yamano","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.12.009_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00097-18","article-title":"TonB-dependent receptor repertoire of Pseudomonas aeruginosa for uptake of siderophore-drug conjugates","volume":"62","author":"Luscher","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01221-20","article-title":"Cefiderocol resistance in Acinetobacter baumannii: roles of \u03b2-Lactamases, siderophore receptors, and penicillin binding protein 3","volume":"64","author":"Malik","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/jac\/dkad172","article-title":"In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa","volume":"78","author":"Gomis-Font","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib10","doi-asserted-by":"crossref","first-page":"e4472","DOI":"10.1093\/cid\/ciaa1909","article-title":"Evolution of cefiderocol non-susceptibility in Pseudomonas aeruginosa in a patient without previous exposure to the antibiotic","volume":"73","author":"Streling","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa081","article-title":"Escherichia coli strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance study","volume":"2","author":"Sato","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.12.009_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00755-18","article-title":"Contribution of active iron uptake to Acinetobacter baumannii pathogenicity","volume":"87","author":"Runci","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2025.12.009_bib13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/genes6041113","article-title":"How porin heterogeneity and trade-offs affect the antibiotic susceptibility of gram-negative bacteria","volume":"6","author":"Ferenci","year":"2015","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.cmi.2025.12.009_bib14","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200896","article-title":"Multidrug-resistant organisms in patients from Ukraine in The Netherlands, March to August 2022","volume":"27","author":"Zwittink","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2025.12.009_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01142-24","article-title":"Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients","volume":"12","author":"Verkaik","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2025.12.009_bib16","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0","year":"2025"},{"key":"10.1016\/j.cmi.2025.12.009_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-022-07653-3","article-title":"The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults","volume":"22","author":"Sieswerda","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmi.2025.12.009_bib19","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinform"},{"key":"10.1016\/j.cmi.2025.12.009_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.cmi.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.2147\/IDR.S392241","article-title":"Resistance to cefiderocol involved expression of PER-1 \u03b2-lactamase and downregulation of iron transporter system in carbapenem-resistant Acinetobacter baumannii","volume":"15","author":"He","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2025.12.009_bib22","volume":"68","author":"Blanco-Mart\u00edn","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2022.115651","article-title":"In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates","volume":"103","author":"Zhang","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10096-022-04526-0","article-title":"Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa","volume":"42","author":"Sadek","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.12.009_bib25","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/jac\/dkae263","article-title":"Impact of chromosomally encoded resistance mechanisms and transferable \u03b2-lactamases on the activity of cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against Pseudomonas aeruginosa","volume":"79","author":"Gonz\u00e1lez-Pinto","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001878","article-title":"Hypermutator strains of Pseudomonas aeruginosa reveal novel pathways of resistance to combinations of cephalosporin antibiotics and beta-lactamase inhibitors","volume":"20","author":"Dulanto Chiang","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cmi.2025.12.009_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12688\/f1000research.29032.2","article-title":"Sustainable data analysis with Snakemake","volume":"10","author":"M\u00f6lder","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.cmi.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"538.e7","DOI":"10.1016\/j.cmi.2022.11.014","article-title":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"29","author":"L\u00f3pez-Causap\u00e9","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.12.009_bib29","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/jac\/dkaa021","article-title":"High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam\/avibactam","volume":"75","author":"Periasamy","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.12.009_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae169","article-title":"Real-world performance of susceptibility testing for cefiderocol: insights from a prospective multicentre study on Gram-negative bacteria","volume":"6","author":"Irigoyen-von-Sierakowski","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/jac\/dkac080","article-title":"Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing","volume":"77","author":"Matuschek","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25006184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:56:12Z","timestamp":1773676572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25006184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1198743X25006184"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.12.009","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CefiderocolFinder: a tool for detecting genetic adaptations implicated in cefiderocol resistance","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}